Stem cell therapy vs conventional treatment is not usually an either-or decision, though it is sometimes presented that way. Conventional treatments for most conditions have been tested in large trials and have established roles. Regenerative approaches are generally discussed as additions or alternatives where conventional options have limits.
The difference in evidence base is the central point. Established treatments have known effect sizes, side effect profiles, and guidelines. Regenerative approaches for many conditions are still being studied, which means outcomes are described in terms of possibility rather than expectation. Neither fact makes one option automatically preferable.
The practical approach is to keep your existing physician involved. Ask how a proposed regenerative treatment would interact with current medication, whether anything would need to change, and what would happen if it does not help. Any provider suggesting you stop established treatment without specialist agreement should be questioned carefully. Bringing the proposed plan to your existing specialist before committing is straightforward and usually welcomed by clinics that are confident in their approach.
